Dentsply Sirona (XRAY) EBITDA (2009 - 2026)

Dentsply Sirona (XRAY) has 18 years of EBITDA data on file, last reported at -$35.0 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA fell 155.56% year-over-year to -$35.0 million; the trailing twelve-month figure through Mar 2026 stood at -$520.0 million (up 39.39% YoY), and the FY2025 full-year result was -$422.0 million, up 51.99% from the prior year.
• EBITDA for Q1 2026 stood at -$35.0 million, up from -$139.0 million in the prior quarter.
• Across five years, EBITDA topped out at $119.0 million in Q2 2022 and bottomed at -$1.2 billion in Q3 2022.
• The 5-year median for EBITDA is -$2.0 million (2023), against an average of -$138.7 million.
• The widest annual swing landed in 2022, when EBITDA plunged 1022.73%; it then jumped 2200.0% in 2024.
• A 5-year view of EBITDA shows it stood at $65.0 million in 2022, then rose by 12.31% to $73.0 million in 2023, then plunged by 797.26% to -$509.0 million in 2024, then soared by 72.69% to -$139.0 million in 2025, then surged by 74.82% to -$35.0 million in 2026.
• The last three EBITDA figures came in at -$35.0 million (Q1 2026), -$139.0 million (Q4 2025), and -$218.0 million (Q3 2025), per Business Quant data.

Peer Comparison